AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frey, A. D.
Right arrow Articles by Kallio, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frey, A. D.
Right arrow Articles by Kallio, P. T.
Agricola
Right arrow Articles by Frey, A. D.
Right arrow Articles by Kallio, P. T.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, February 2001, p. 680-687, Vol. 67, No. 2
0099-2240/01/$04.00+0   DOI: 10.1128/AEM.67.2.680-687.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Dissection of Central Carbon Metabolism of Hemoglobin-Expressing Escherichia coli by 13C Nuclear Magnetic Resonance Flux Distribution Analysis in Microaerobic Bioprocesses

Alexander D. Frey,1 Jocelyne Fiaux,2 Thomas Szyperski,2,dagger Kurt Wüthrich,2 James E. Bailey,1 and Pauli T. Kallio1,*

Institute of Biotechnology1 and Institute of Molecular Biology and Biophysics,2 ETH Zürich, CH-8093 Zürich, Switzerland

Received 21 July 2000/Accepted 29 November 2000


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Escherichia coli MG1655 cells expressing Vitreoscilla hemoglobin (VHb), Alcaligenes eutrophus flavohemoprotein (FHP), the N-terminal hemoglobin domain of FHP (FHPg), and a fusion protein which comprises VHb and the A. eutrophus C-terminal reductase domain (VHb-Red) were grown in a microaerobic bioreactor to study the effects of low oxygen concentrations on the central carbon metabolism, using fractional 13C-labeling of the proteinogenic amino acids and two-dimensional [13C, 1H]-correlation nuclear magnetic resonance (NMR) spectroscopy. The NMR data revealed differences in the intracellular carbon fluxes between E. coli cells expressing either VHb or VHb-Red and cells expressing A. eutrophus FHP or the truncated heme domain (FHPg). E. coli MG1655 cells expressing either VHb or VHb-Red were found to function with a branched tricarboxylic acid (TCA) cycle. Furthermore, cellular demands for ATP and reduction equivalents in VHb- and VHb-Red-expressing cells were met by an increased flux through glycolysis. In contrast, in E. coli cells expressing A. eutrophus hemeproteins, the TCA cycle is running cyclically, indicating a shift towards a more aerobic regulation. Consistently, E. coli cells displaying FHP and FHPg activity showed lower production of the typical anaerobic by-products formate, acetate, and D-lactate. The implications of these observations for biotechnological applications are discussed.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Hemoglobins are a specific group of oxygen-binding proteins that can be found in mammals, plants, and microorganisms (15). The homodimeric hemoglobin of Vitreoscilla (VHb) is the best characterized bacterial hemoglobin. The expression of VHb is up-regulated by oxygen limitation (hypoxia) in Vitreoscilla (50), but its physiological functions have not yet been entirely elucidated. Nonetheless, heterologous expression of VHb has been used to alleviate physiologically unfavorable effects of oxygen limitation and to improve growth properties and productivity of various microorganisms, plants, and mammalian cells that yield industrially important metabolites (7, 18, 21, 28-30, 32, 35).

Previous research on the effects arising from heterologous VHb expression has mainly focused on the operation of the respiratory chain. Expression of VHb in Escherichia coli cells lacking either cytochrome o (aerobic terminal oxidase) or cytochrome d complexes (microaerobic terminal oxidase) revealed a 5-fold increase in cytochrome o (in a cyd mutant, cyo+ strain) and a 1.5-fold increase in cytochrome d (in cyd+, cyo mutant strain) complexes relative to wild-type cells (48). These results have led to the hypothesis that VHb is able to increase the effective intracellular oxygen concentration with concomitant increase of the amount of cytochrome o complexes (20): the proton translocation activity of cytochrome o complexes is characterized by a higher H/O ratio than cytochrome d complexes and is able to generate a larger proton gradient across the cell membrane (25, 36, 38). VHb-expressing cells are indeed able to generate a larger proton flux per reduced oxygen molecule than control cells and have a 30% higher ATPase activity and a 65% higher ATP turnover rate (8, 20).

Furthermore, it has also been reported that the steady-state NAD(P)H level is 1.8-fold lower in a VHb-expressing strain than in control cells grown under nearly anoxic conditions (47), i.e., cells are in a more reduced state under oxygen-limited conditions (16). Anoxia is known to reduce electron flow through the respiratory chain so that NAD(P)H is consumed more slowly. Therefore, one may hypothesize that, under low oxygen tension, the presence of VHb in E. coli increases the electron flux through the respiratory chain. Moreover, Tsai et al. (47) postulated that this shift in the NAD+/NADH concentration ratio might have implications on key steps of the central carbon metabolism in VHb-expressing E. coli. Therefore, metabolic flux analysis (MFA) was performed and a metabolic model suggested that VHb-positive cells direct a higher fraction of glucose through the pentose phosphate pathway (PPP) and channel less acetyl coenzyme A (AcCoA) through the tricarboxylic acid cycle (TCA) than wild-type E. coli (49). Direction of additional glucose through PPP generates an excess amount of NADPH and results in a transhydrogenation reaction, which creates an H+ flux from NADPH to NAD+. VHb-expressing cells also displayed strongly reduced formate and D-lactate excretion levels relative to those of controls (49).

Recently, we constructed a novel set of expression systems for native and engineered hemoglobin proteins (12). The native proteins used were VHb and the flavohemoprotein (FHP) of Alcaligenes eutrophus (9). FHP is a member of the FNR-like proteins (23) and contains an N-terminal hemoglobin (FHPg) and a C-terminal redox-active (Red) domain. The Red domain was fused with VHb to generate the VHb-Red fusion protein. In addition, the hemoglobin domain (FHPg), which shares high sequence homology with VHb, was truncated from the reductase domain and was functionally expressed in E. coli. The expression of the hemoglobins showed various interesting features, such as significantly improved growth rates and changes in activity of metabolic pathways under hypoxia (12).

The ratios of intracellular metabolic fluxes in the central carbon metabolism of E. coli MG1655 cells grown under oxygen-limited conditions have previously been determined using biosynthetically directed fractional 13C-labeling of amino acids and two-dimensional (2D) [13C, 1H]-correlation nuclear magnetic resonance (NMR) spectroscopy (11). This investigation, which serves as a reference for the presently studied hemoglobin-expressing cells, showed that, under microaerobic conditions, the topology of the active pathways is characteristic of anaerobic metabolism, as was primarily evidenced by the activity of the pyruvate-formate lyase and the suppression of 2-oxoglutarate dehydrogenase activity. This result is at variance with previously assumed aerobic configurations and illustrates the importance of experimental characterization of the topology of active pathways.

Further studies of the central carbon metabolism of hemoglobin-expressing cells promise to lead to new insights into the cellular physiology, which in turn may support the design of improved strains for biotechnology. Therefore, we applied the recently developed approach of biosynthetically directed fractional labeling of proteinogenic amino acids (43-46) for the assessment of intracellular carbon flux ratios by using a variety of hemoglobin-expressing E. coli strains.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Strains and plasmids. The plasmids pPPC1 (which carries the Vitreoscilla vhb gene), pAX1 (which carries the A. eutrophus hemoglobin gene domain [fhpg]), pAX5 (which contains the native flavohemoglobin gene [fhp] of A. eutrophus), and pAX4 (which carries the gene fusion between the vhb gene and the FHP reductase domain coding sequence of A. eutrophus [vhb-red]) were used to study physiological consequences of globin expression in E. coli MG1655 (lambda -, F-) (Cold Spring Harbor Laboratory). The construction of the plasmids has been described previously (12, 22).

Microaerobic bioreactor cultivations. Cultivations of E. coli MG1655 were performed under microaerobic conditions (concentration of O2, <= 0.02 mmol/liter) in a SixFors bioreactor unit (Infors, Bottmingen, Switzerland) in a fed-batch mode using a minimal medium containing glucose as the sole carbon source (4 g of glucose/liter) (22). Based on previous experiments, which showed lower glucose consumption for E. coli cells expressing the A. eutrophus hemoglobin genes (fhpg and fhp), the glucose concentration of the medium was reduced to 2 g/liter for these strains. This modification prevents both glucose accumulation and dilution of the 13C-labeled substrate with unlabeled glucose. The bioreactor parameters were as follows: working volume, 300 ml; stirrer speed, 300 rpm; temperature, 37°C; aeration rate, 120 ml of air/min; and pH of 7.0 ± 0.2, adjusted with addition of either 2 M NaOH or 2 M H3PO4.

Inocula were grown for 14 h in 50-ml shake flasks containing 10 ml of Luria-Bertani media (39) supplemented with ampicillin (100 µg/ml) at 37°C and 250 rpm. Inoculation of the bioreactors was standardized to obtain a starting absorption (A600) of 0.2. The expression of the various hemoglobins was induced with IPTG (isopropyl-beta -D-thiogalactopyranoside) to a final concentration of 0.5 mM at an A600 of approx 1. Feeding of the cultures was started at a rate of 1 ml/h at an A600 of 2.5, which was increased to 2 ml/h when the fractional 13C-labeling started at an A600 of 4.5. The labeling medium contained a mixture of 10% uniformly labeled [13C]glucose (Isotech, Miamisburg, Ohio) and 90% unlabeled glucose. At an A600 of 7, the cells were harvested for NMR measurements.

O2 consumption and CO2 production of the cells were monitored using an emission monitor (Emission Monitor Type 3427; Brüel & Kjaer), and dissolved oxygen concentration of the cultures was tightly controlled with a polarographic electrode (Mettler-Toledo, Nänikon-Greifensee, Switzerland). Growth of the cultures was monitored with a spectrophotometer (Perkin-Elmer) at 600 nm every 30 min. Cellular dry weight (CDW) was determined at the beginning (A600 = 4.5) and the end of the labeling phase (A600 = 7) (40).

Biological activity of expressed hemoglobin proteins. The biological activity of the expressed hemoglobin proteins was confirmed by a CO-binding activity assay (17).

Quantitative analysis of by-products and intracellular metabolites. By-product concentrations were measured enzymatically with a Beckman SYNCHRON CX5CE autoanalyzer at 1-h intervals. Ethanol and residual glucose concentrations were determined using Beckman alcohol (no. 445900) and glucose (no. 442640) kits, respectively. The acetate kit (no. 148261) was purchased from Roche Diagnostics. Quantifications of D-lactate, succinate, and formate concentrations were performed using enzymatic assays adapted for the Beckman autoanalyzer system (5, 49).

Quantification of the intracellular metabolites pyruvate, ATP, and ADP was performed using perchloric acid for extraction of the metabolites (2, 10). The concentrations were measured with a Beckman autoanalyzer using enzymatic assays (5, 10). Enzymes were obtained from Roche Molecular Biochemicals. According to the supplier information, unspecific reactions contribute less than 1% to the measured concentrations, which we verified experimentally (data not shown).

Sample preparation and 2D [13C, 1H]-COSY NMR measurements. Fractionally labeled cells were hydrolyzed in 6 N HCl at 110°C, and the NMR spectra of the amino acid mixtures were recorded at 40°C and at a proton resonance frequency of 400 MHz, using a Varian Inova 400 spectrometer. Two proton-detected 2D [13C, 1H] heteronuclear single quantum coherence spectra were recorded for each sample (6). Pulsed-field gradients were used for coherence pathway rejection (4, 52), and the decoupling scheme WALTZ (42) was applied during detection. The spectra containing the aliphatic resonances were recorded in 12.5 h (1,400 by 256 complex points; t1max = 412 ms; t2max = 128 ms; 1.5-s relaxation delay between scans) with the carrier frequency set to 42.5 ppm and a spectral width of 33.8 ppm. The spectra for the aromatic resonances were recorded in 7.5 h (950 by 512 complex points; t1max = 412 ms; t2max = 109 ms; 1.5-s relaxation delay between scans) with the 13C-carrier frequency set to 123.8 ppm and a spectral width of 22.8 ppm. Spectra were transformed using the program PROSA (14). The digital resolution after zero-filling was 0.9 Hz/point along omega 1 and 2.0 Hz/point along omega 2 for the spectrum with the aliphatic resonances and was 0.6 Hz/point along omega 1 and 4.6 Hz/point along omega 2, respectively, for the spectra containing the aromatic resonances. The overall degree of the 13C labeling of the amino acids, P1, was measured from 1D 1H-NMR spectra (t1max = 1.024 s; 8-s interscan delay), as shown in Fig. 1. The resulting value of P1 was in good agreement with the value calculated from the fraction of [13C6]glucose in the minimal medium and the fraction of 13C-labeled biomass assessed via first-order wash-out kinetics (40). The value for P1 was independently confirmed from analysis of the scalar coupling fine structure of Leu-beta (43). Forty-two individual 13C-13C coupling fine structures were analyzed in the correlation spectra, and the relative abundances of intact carbon fragments present in eight principal intermediates of the central carbon metabolism were derived according to Szyperski (43), using the program FCAL (46). Flux ratios through several key pathways in the cellular central metabolism were then calculated from the abundances of fragments as described previously (40, 43).


View larger version (20K):
[in this window]
[in a new window]
 
FIG. 1.   Determination of the degree of overall 13C labeling of the biomass from a 1D 1H-NMR spectrum. (a) Region of the 1D 1H-NMR spectrum recorded for the hydrolyzed biomass comprising the aromatic resonances. Several well-resolved peaks allow observation of the 13C satellites. (b) Expansion showing a well-resolved resonance (unassigned). The satellite doublet arising from protons bound to 13C and the corresponding 12C-H peak are indicated by arrows. The ratio of the sum of the integrals of the two satellites to the total integral of all three peaks yields the overall labeling degree of the biomass (4.5% in this case).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Physiological characterization of hemoglobin-expressing strains. The E. coli strains MG1655:pPPC1, MG1655:pAX1, MG1655:pAX4, and MG1655:pAX5 displayed CO-binding activities that are indicative of the expression of biochemically active hemoglobin proteins. The absorption spectra of the various hemoglobins corresponded to the values reported previously (data not shown) (12).

The MG1655 strains that coexpress hemoglobin and reductase activities, FHP and VHb-Red, grew fastest, exhibiting specific growth rates (µ) of 0.168 and 0.180 h-1, respectively. The E. coli strains expressing either FHPg or VHb grew with a µ of 0.132 and 0.148 h-1, respectively, during the 13C-labeling phase from an A600 of 4.5 to an A600 of 7 (Fig. 2).


View larger version (17K):
[in this window]
[in a new window]
 
FIG. 2.   Growth trajectories of the four hemoglobin-expressing E. coli MG1655 strains used for this study, when grown in a minimal medium under hypoxic conditions. The expression of the proteins was induced at an A600 of 1, and the fractional 13C-labeling was started at an A600 of approx 4.5. The cells were harvested for NMR analysis at the end of the cultivations, with an A600 of 7. , MG1655:pPPC1, which expresses the VHb protein; , MG1655:pAX5, which expresses the FHP protein; open circle , MG1655:pAX1, which expresses the FHPg protein; ×, MG1655:pAX4, which expresses the VHb-Red protein.

Glucose uptake and the production of D-lactate, acetate, ethanol, and succinate were calculated and normalized to CDW to obtain the specific production rates (qp; units, millimoles/hour/gram) (Table 1). Evaluation of qp for subsequent time intervals during the labeling phase revealed a slight decrease in the specific production rates of all assayed metabolites within the time course of the cultivation. We did not take these variations into account since the values assessed by the NMR analysis also represent a global view over the whole labeling phase.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Physiological data of the five E. coli strains MG1655:pAX1 (FHPg), MG1655:pAX5 (FHP), MG1655:pPPC1 (VHb), MG1655:pAX4 (VHb-Red), and MG1655 (control) assessed during 13C-labeling phase

We observed substantially lower formate production rates for the strains expressing A. eutrophus FHP (MG1655:pAX5; 0.14 mmol/h/g) or the truncated flavohemoglobin FHPg (MG1655:pAX1; 1.30 mmol/h/g) than for VHb (MG1655:pPPC1; 2.59 mmol/h/g) and VHb-Red (MG1655:pAX4; 3.31 mmol/h/g). FHP and FHPg also showed decreased D-lactate production relative to those of the VHb- and VHb-Red-expressing strains, and less pronounced reduction was observed for acetate production. The specific acetate production rates were similar for the MG1655 strains expressing VHb, FHPg, and FHP, whereas the strain expressing VHb-Red excreted approximately twofold more acetate into the culture media (Table 1). Furthermore, we found an approximately twofold higher glucose consumption rate for the strains expressing VHb and VHb-Red (3.97 and 4.60 mmol/h/g, respectively) than for the A. eutrophus FHP- and FHPg-expressing strains (2.32 and 2.88 mmol/h/g, respectively). The control strain showed the highest glucose consumption rate to be 5.45 mmol/h/g of CDW (Table 1).

Monitoring the exhaust gases yielded specific CO2 production (qCO2) and O2 consumption (qO2) rates. The strains expressing FHP and FHPg revealed higher respiratory activities than either the VHb- or VHb-Red expressing strains or the control strain, as evidenced by an at least twofold higher qCO2 and qO2 values (Table 2). The respiratory quotient (RQ), such that RQ = qCO2/qO2, is an indicator for the metabolic state of the cells. The calculated RQ values for MG1655:pAX1 and for MG1655:pAX5 were 0.84 and 0.95, respectively, whereas those for VHb- or VHb-Red-expressing strains were significantly lower, being 0.48 and 0.69, respectively. Thus, the expression of A. eutrophus FHP or FHPg increased the RQ by 100% (MG1655:pAX5) and 80% (MG1655:pAX1), respectively, relative to the MG1655:pPPC1 strain expressing Vitreoscilla hemoglobin (Table 1).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Concentrations of intracellular metabolites pyruvate, ATP, and ADP in E. coli strains MG1655:pAX1 (FHPg), MG1655:pAX5 (FHP), MG1655:pPPC1 (VHb), MG1655:pAX4 (VHb-Red), and MG1655 (control)a

Interestingly, we could assess a twofold higher intracellular pyruvate concentration for the strains expressing Vitreoscilla hemoglobin than for the strains possessing A. eutrophus hemoglobin proteins (Table 2). Pyruvate is the endproduct of glucose breakdown in glycolysis and is further channeled towards the TCA cycle or is consumed in the anaerobic pathways, leading to the formation of the typical by-products of anaerobic growth. Thus, this difference in intracellular pyruvate concentration can be explained by a higher glucose flow through the glycolytic pathway in MG1655:pPPC1 and MG1655:pAX4 cells. The production of pyruvate was identical with the VHb- or VHb-Red-expressing strains. On the other hand, the analysis of ATP and ADP contents did not reveal any significant differences among the different hemoglobin-expressing strains under study, but the control showed an approximately twofold lower ATP/ADP ratio than the hemoglobin-expressing strains (Table 2).

Validation of physiological data. We performed a carbon balance analysis for all hemoglobin-expressing strains, taking into account the glucose uptake, production of biomass, CO2 evolution, and excretion of by-products. The carbon recovery calculated as the ratio of C output to C uptake was larger than 93% in all cases, i.e., the carbon balance could be closed to within a few percentage points (Table 3).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   Carbon balance for the validation of the physiological data in MG1655:pAX1 (FHPg), MG1655:pAX5 (FHP), MG1655:pPPC1 (VHb), MG1655:pAX4 (VHb-Red), and MG1655 (control)a

Analysis of the 2D [13C, 1H]-correlation spectroscopy (COSY) spectra and derivation of metabolic flux ratios. The 13C-labeling experiments revealed major differences in the central carbon metabolism when comparing VHb- and VHb-Red-expressing cells to FHPg- and FHP-expressing cells. VHb- and VHb-Red-positive cells yielded labeling patterns similar to those previously observed for anaerobically grown wild-type E. coli cells (43) and microaerobic MG1655 cells (11), whereas for FHPg- and FHP-expressing cells, a more aerobic fluxome was found (Fig. 3 and Table 4).


View larger version (66K):
[in this window]
[in a new window]
 
FIG. 3.   Flux ratios and interaction of glycolysis and the TCA cycle in the central carbon metabolism of hemoglobin-expressing microaerobic E. coli MG1655 cells. (A) Flux ratios of wild-type E. coli cells (11), VHb-expressing cells, and VHb-Red-expressing cells (from top to bottom of the boxes). (B) Flux ratios of FHPg- and FHP-expressing E. coli cells (from top to bottom of the boxes). Glycolysis (left) and the TCA cycle (right) are highlighted. Enzymatically measured by-products and glucose are given in bold italics. Carbon fragment patterns of the boxed metabolites were directly determined by [13C, 1H]-COSY of proteinogenic amino acids. The fractions of molecules given in boxes are synthesized via the reactions pointing at them, and numbers in ellipses indicate the amount of reversible interconversion of the molecules. Enzyme names are given in italics. Active pathways are shown with solid arrows. Dashed arrows indicate that the represented enzymatic conversion is inactive. Abbreviations: CIT, citrate; MAL, malate; OAA, oxaloacetate; OGA, oxoglutarate; PEP, phosphoenolpyruvate; PYR, pyruvate; ME, malic enzyme; PFL, pyruvate-formate lyase; PEP-CARB, phosphoenolpyruvate carboxylase; CIT-SYN, citrate synthase; GOX shunt, glyoxylate shunt; OGA-DH, oxoglutarate dehydrogenase.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 4.   Origin of intermediate metabolites in the four cultures of Table 1a

The labeling pattern of oxaloacetate (OAA) of VHb- and VHb-Red-expressing cells revealed that OAA is solely derived from phosphoenolpyruvate by carboxylation (33). Thus, the TCA cycle operates in a branched fashion to generate exclusively building blocks for biosynthesis (Table 4). In contrast, for microaerobically growing strains expressing either FHP or FHPg, only 44 and 88% of the OAA, respectively, was generated through the anaplerotic reaction, indicating that, in these cells, the TCA cycle also serves for ATP production via respiration. Concomitantly, the activity of the pyruvate-formate lyase (Pfl) (26) is suppressed as respiration is activated. Further analysis showed increased turnover ratios for the interconversion of pyruvate to AcCoA and formate by Pfl for the strains expressing VHb (0.65) and VHb-Red (0.73) and to a smaller extent for cells expressing FHPg (0.19). In MG1655:pAX5 (FHP) cells, Pfl activity is not detectable, which is compatible with our physiological data displaying a very low specific formate production rate for the FHP-expressing strain (Fig. 3; Table 4).

An additional notable observation is that the AcCoA pool was diluted with unlabeled molecules, which probably originated from the external acetate pool; the 13C isotopomer abundances found for AcCoA differed slightly from those that one would expect if pyruvate were the sole carbon source for AcCoA synthesis (Table 4). The 13C enrichments of AcCoA and corresponding intermediates are therefore not strictly uniform, but the deviations from uniform 13C enrichment are so small that they were not detectable with the program FCAL; calculation of flux ratios in the TCA cycle based on tracing intact C3 fragments is in any case hardly affected by such a dilution at the level of AcCoA. The present observation of a decreased isotope enrichment of the AcCoA pool supports the earlier suggestion that exchange of intra- and extracellular acetate in hypoxic E. coli cells might be a general metabolic configuration: Sauer et al. (41) postulated the presence of reversible exchange fluxes between intra- and extracellular acetate pools as well as the reversibility of the reactions connecting AcCoA to acetate (Table 4).

Finally, we also observed that the glyoxylate shunt is not active in the presently studied cells (19, 27). Furthermore, the conversion of malate to pyruvate catalyzed by the malic enzyme does not contribute to the labeling pattern observed in FHP- and FHPg-expressing strains (Fig. 3). For VHb and VHb-Red cells, these activities could not be assessed (Table 4), since the Ca-C' fragment, which would be traced from OAA to pyruvate to determine malic enzyme activity, is not generated when the TCA cycle operates in a branched fashion.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The expression of VHb, VHb-Red, FHPg, and FHP was previously shown to improve hypoxic growth properties of E. coli MG1655 cells in bioreactor cultivations (12). Although the expression of these hemoglobin proteins is able to positively modulate the microaerobic growth of E. coli, little is known about the underlying changes of metabolic configurations induced by the expression of these heterologous globins. Therefore, we have studied the microaerobic carbon metabolism of E. coli MG1655 cells expressing VHb, VHb-Red, FHPg, or FHP by using fractional 13C-labeling and 2D NMR spectroscopy (43-46). In addition, we analyzed the by-product excretion and intracellular metabolite content in order to unravel more accurately the changes of carbon metabolism. Our results revealed major differences in the metabolic states between VHb- and VHb-Red-producing E. coli strains on the one hand and FHPg- and FHP-expressing E. coli strains on the other hand.

The genetic approach to alleviate adverse effects of oxygen limitation by VHb-expression has been extensively studied in E. coli. Previously, a mathematical model conjectured that VHb is able to increase the intracellular oxygen tension and to activate both terminal oxidases in E. coli, albeit to different extents (20, 49). Thus, the model indirectly suggested that VHb expression is able to shift the global microaerobic regulatory network to a more aerobic regime. This hypothesis was supported by results of Tsai et al. (48) revealing a 5-fold increase in cytochrome o and a 1.5-fold increase in cytochrome d content in VHb-expressing cells relative to those of controls. In addition, the specific activity of cytochrome o was enhanced by 50% relative to those of VHb-negative controls. The cytochrome o complex is able to extrude two protons per oxygen molecule reduced, whereas the cytochrome d complex does not function as a proton pump (38). VHb-expressing cells do actually display a higher transmembrane proton gradient and a higher yield of membrane-translocated protons per oxygen molecule reduced when compared to controls (20, 48). These findings are in qualitative agreement with previous 31P-NMR results showing that VHb-expressing cells have a 65% higher ATP turnover rate than controls. The reentry of the proton flow into the cell via ATPase yields up to 30% higher ATPase activity and ATP production than controls (8, 20).

Keeping the above-mentioned findings in mind and taking into account the present data of the VHb-expressing E. coli which showed an interrupted TCA cycle, we tried to integrate all the information into a model for microaerobic growth of VHb-expressing E. coli. Interruption of the TCA cycle is normally regarded as a characteristic of anaerobic growth. However, it has also been shown for aerobically growing E. coli cells that the TCA cycle can operate in a branched fashion once the cellular energy demands are satisfied with energy derived from glycolysis (1). A study by Tsai et al. (49) showed that the carbon fluxes through the TCA cycle are concomitantly decreased with increasing VHb concentration. As a consequence, the expression of increasing amounts of VHb reduces the carbon flux entering the TCA cycle via AcCoA but slightly increases the carbon flux through the anaplerotic reaction connecting glycolysis to the TCA cycle. Therefore, we may hypothesize that the TCA cycle is interrupted above a threshold VHb concentration, as shown in this study for VHb- and VHb-Red-expressing E. coli cells. The absence of cyclic TCA activity leads to less efficient oxidation of carbon sources and concomitantly to a decreased generation of reducing equivalents and ATP. Higher glycolytic activity in VHb-expressing cells may then satisfy the ATP and NAD(P)H demands for growth and maintenance. To support this hypothesis, we included some previously published NMR data on hemoglobin-negative control cells in Table 4 (11). Comparison of the data on VHb- and VHb-Red-expressing cells with the VHb-negative control reveals similar flux ratios. However, additional data on wild-type E. coli MG1655 cells grown with the same experimental conditions reveal a higher production of formate and an increased consumption of glucose but a lower growth rate relative to the hemoglobin-expressing strain (Table 1). These findings may confirm our hypothesis that VHb and VHb-Red expression may enable the cells to operate their metabolism more efficiently. Therefore, the lack of functional TCA cycle activity in these strains might not result from anaerobiosis but simply from the fact the cellular energy demands can be satisfied by a more efficient ATP generation system.

Unfortunately, the physiological role of FHP either in its native host, A. eutrophus, or in other heterologous expression systems is poorly characterized. FHP expression, like that of VHb, is induced under microaerobic conditions and may interact with gas metabolism during denitrification in A. eutrophus (9, 37). However, fhp mutants did not show any difference relative to wild-type cells when grown anaerobically with nitrite as a sole electron acceptor, but did not transiently accumulate nitrous oxide. Preliminary attempts to demonstrate nitric oxide reduction with purified FHP and NADH as an electron donor were unsuccessful (9), and the role of flavohemoglobins in the detoxification of nitric oxide is still under discussion (24, 31). Since our previous results have shown that FHP can help to support growth of E. coli under microaerobic conditions (12), it would nonetheless appear that FHP is able to increase the free intracellular oxygen concentration in E. coli. This hypothesis is supported by our data showing that FHP and FHPg expression leads to a higher oxygen uptake rate than in VHb-expressing cells and inactivation of the highly O2-sensitive enzyme Pfl, which was, rather unexpectedly, found to be active in VHb- and VHb-Red-expressing cells.

Recently, Gardner et al. (13) purified FHP, determined the kinetic properties for oxygen binding and release (kon = 50 µM-1 s-1, koff = 0.2 s-1), and found that the dissociation constant differs strongly from the values reported for VHb (kon = 78 µM-1 s-1, koff = 5,600 s-1) (34, 51). The association equilibrium constants (K) determined for FHP and VHb attribute high oxygen affinity to FHP (K = 250 µM-1) and low oxygen affinity to VHb (K = 0.014 µM-1). Due to the very high values for koff, VHb-expressing cells have previously been proposed to scavenge oxygen and possibly provide O2 rapidly to respiratory complexes in E. coli (20, 47-49). The mechanism of biochemical action of FHP globin on the cellular metabolism of E. coli is still unknown.

In this study, we have shown that inverse metabolic engineering (3) can be used to improve metabolic efficiency of microaerobic cells by expression of heterologous globin genes. Through introducing FHP and FHPg into E. coli cells, we were able to reduce glucose consumption by approximately 50% relative to that of VHb- or VHb-Red-expressing cells without affecting cell growth. This has direct implications for economical aspects of potential biotechnological applications, promising lowered production costs.


    ACKNOWLEDGMENTS

This work was supported by the ETH Zürich and the Swiss Priority Program for Biotechnology (SPP2).


    FOOTNOTES

* Corresponding author. Mailing address: Institute of Biotechnology, ETH Zürich, CH-8093 Zürich, Switzerland. Phone: 41 1 633 34 46. Fax: 41 1 633 10 51. E-mail: kallio{at}biotech.biol.ethz.ch.

dagger Present address: Department of Chemistry, State University of New York, Buffalo, NY 14260.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Amarasingham, C. R., and B. C. Davis. 1965. Regulation of delta -ketoglutarate dehydrogenase formation in Escherichia coli. J. Biol. Chem. 240:3664-3668[Free Full Text].
2. Babul, J., D. Clifton, M. Kretschmer, and D. G. Fraenkel. 1993. Glucose metabolism in Escherichia coli and the effect of increased amount of aldolase. Biochemistry 32:4685-4692[CrossRef][Medline].
3. Bailey, J. E., A. Sburlati, V. Hatzimanikatis, K. Lee, W. A. Renner, and P. S. Tsai. 1996. Inverse metabolic engineering: a strategy for directed genetic engineering of useful phenotypes. Biotechnol. Bioeng. 52:109-121.
4. Bax, A., and S. Pochapsky. 1992. Optimized recording of heteronuclear multidimensional NMR spectra using pulsed field gradients. J. Magn. Reson. 99:638-643.
5. Bergmeyer, J., and M. Gassl. 1984. Metabolites 1: carbohydrates. VCH, WeinheimWeinheim, Germany.
6. Bodenhausen, G., and D. J. Ruben. 1980. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett. 69:185-188[CrossRef].
7. Brünker, P., W. Minas, P. T. Kallio, and J. E. Bailey. 1998. Genetic engineering of an industrial strain of Saccharopolyspora erythraea for stable expression of the Vitreoscilla haemoglobin gene (vhb). Microbiology 144:2441-2448[Abstract].
8. Chen, R., and J. E. Bailey. 1994. Energetic effect of Vitreoscilla hemoglobin expression in Escherichia coli: an online 31P NMR and saturation transfer study. Biotechnol. Prog. 10:360-364[CrossRef].
9. Cramm, R., R. A. Siddiqui, and B. Friedrich. 1994. Primary sequence and evidence for a physiological function of the flavohemoprotein of Alcaligenes eutrophus. J. Biol. Chem. 269:7349-7354[Abstract/Free Full Text].
10. Emmerling, M., J. E. Bailey, and U. Sauer. 1999. Glucose catabolism of Escherichia coli strains with increased activity and altered regulation of key glycolytic enzymes. Metabol. Engin. 1:117-127.
11. Fiaux, J., C. I. J. Andersson, N. Holmberg, L. Bülow, P. T. Kallio, T. Szyperski, J. E. Bailey, and K. Wüthrich. 1999. 13C NMR flux ratio analysis of Escherichia coli central carbon metabolism in microaerobic bioprocesses. J. Am. Chem. Soc. 121:1407-1408[CrossRef].
12. Frey, A. D., J. E. Bailey, and P. T. Kallio. 2000. Expression of Alcaligenes eutrophus flavohemoprotein and engineered Vitreoscilla hemoglobin-reductase fusion protein for improved hypoxic growth of Escherichia coli. Appl. Environ. Microbiol. 66:98-104[Abstract/Free Full Text].
13. Gardner, P. R., A. M. Gardner, L. A. Martin, Y. Dou, T. Li, J. S. Olson, H. Zhu, and A. F. Riggs. 2000. Nitric-oxide dioxygenase activity and function of flavohemoglobins. J. Biol. Chem. 275:31581-31587[Abstract/Free Full Text].
14. Güntert, P., V. Dötsch, G. Wider, and K. Wüthrich. 1992. Processing of multidimensional NMR data with the new software Prosa. J. Biomol. NMR 2:619-629[CrossRef].
15. Hardison, R. 1998. Hemoglobins from bacteria to man: evolution of different patterns of gene expression. Exp. Biol. 201:1099-1117.
16. Harrison, D. E., and B. Chance. 1970. Fluorimetric technique for monitoring changes in the level of reduced nicotinamide nucleotides in continuous cultures of microorganisms. Appl. Microbiol. 19:446-450[Medline].
17. Hart, R. A., and J. E. Bailey. 1991. Purification and aqueous 2-phase partitioning properties of recombinant Vitreoscilla hemoglobin. Enzyme Microb. Technol. 13:788-795[CrossRef][Medline].
18. Holmberg, N., G. Lilius, J. E. Bailey, and L. Bülow. 1997. Transgenic tobacco expressing Vitreoscilla hemoglobin exhibits enhanced growth and altered metabolite production. Nat. Biotechnol. 15:244-247[CrossRef][Medline].
19. Holms, W. H. 1986. The central metabolic pathways of Escherichia coli: relationship between flux and control at a branch point, efficiency of conversion to biomass, and excretion of acetate. Curr. Top. Cell. Regul. 28:69-105[Medline].
20. Kallio, P. T., D. J. Kim, P. S. Tsai, and J. E. Bailey. 1994. Intracellular expression of Vitreoscilla hemoglobin alters Escherichia coli energy metabolism under oxygen-limited conditions. Eur. J. Biochem. 219:201-208[Medline].
21. Kallio, P. T., and J. E. Bailey. 1996. Intracellular expression of Vitreoscilla hemoglobin (VHb) enhances total protein secretion and improves the production of alpha -amylase and neutral protease in Bacillus subtilis. Biotechnol. Prog. 12:31-39[CrossRef][Medline].
22. Kallio, P. T., P. S. Tsai, and J. E. Bailey. 1996. Expression of Vitreoscilla hemoglobin is superior to horse heart myoglobin or yeast flavohemoglobin expression for enhancing Escherichia coli growth in a microaerobic bioreactor. Biotechnol. Prog. 12:751-757[CrossRef][Medline].
23. Karplus, P. A., M. J. Daniels, and J. R. Herriott. 1991. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family. Science 251:60-66[Abstract/Free Full Text].
24. Kim, S. O., Y. Orii, D. Lloyd, M. N. Hughes, and R. K. Poole. 1999. Anoxic function for the Escherichia coli flavohaemoglobin (Hmp): reversible binding of nitric oxide and reduction to nitrous oxide. FEBS Lett. 445:389-394[CrossRef][Medline].
25. Kita, K., K. Konishi, and Y. Anraku. 1986. Purification and properties of two terminal oxidase complexes of Escherichia coli aerobic respiratory chain. Methods Enzymol. 126:94-113[Medline].
26. Knappe, J., F. A. Neugebauer, H. P. Blaschkowski, and M. Gänsler. 1984. Post-translational activation introduces a free radical into pyruvate formate-lyase. Proc. Natl. Acad. Sci. USA 81:1332-1335[Abstract/Free Full Text].
27. Kornberg, H. L. 1966. The role and control of the glyoxylate cycle in Escherichia coli. Biochem. J. 99:1-11[Medline].
28. Liu, S.-C., B. Ogretmen, Y. Y. Chuang, and B. C. Stark. 1992. Selection and characterization of alpha -amylase-overproducing recombinant Escherichia coli containing the bacterial hemoglobin gene. Appl. Microbiol. Biotechnol. 38:239-242[Medline].
29. Liu, S.-C., D. A. Webster, M. L. Wei, and B. C. Stark. 1996. Genetic engineering to contain the Vitreoscilla hemoglobin gene enhances degradation of benzoic acid by Xanthomonas maltophilia. Biotechnol. Bioeng. 49:101-105[CrossRef].
30. Magnolo, S. K., D. L. Leenutaphong, J. A. DeModena, J. E. Curtis, J. E. Bailey, J. L. Galazzo, and D. E. Hughes. 1991. Actinorhodin production by Streptomyces coelicolor and growth of Streptomyces lividans are improved by the expression of a bacterial hemoglobin. Bio/Technology 9:473-476[CrossRef][Medline].
31. Membrillo-Hernández, J., M. D. Coopamah, M. F. Anjum, T. M. Stevanin, A. Kelly, M. N. Hughes, and R. K. Poole. 1999. The flavohemoglobin of Escherichia coli confers resistance to a nitrosating agent, a "nitric oxide releaser," and paraquat and is essential for transcriptional responses to oxidative stress. J. Biol. Chem. 274:748-754[Abstract/Free Full Text].
32. Minas, W., P. Brünker, P. T. Kallio, and J. E. Bailey. 1998. Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol. Prog. 14:561-566[CrossRef][Medline].
33. Morikawa, M., K. Izui, M. Taguchi, and H. Katsuki. 1980. Regulation of Escherichia coli phosphoenolpyruvate carboxylase by multiple effectors in vivo. Estimation of the activities in the cells grown on various compounds. J. Biochem. 87:441-449[Abstract/Free Full Text].
34. Orii, Y., and D. A. Webster. 1986. Photodissociation of oxygenated cytochrome o (Vitreoscilla) and kinetic studies of reassociation. J. Biol. Chem. 261:3544-3547[Abstract/Free Full Text].
35. Pendse, G. J., and J. E. Bailey. 1994. Effect of Vitreoscilla hemoglobin expression on growth and specific tissue plasminogen activator productivity in recombinant chinese hamster ovary cells. Biotechnol. Bioeng. 44:1367-1370[CrossRef].
36. Poole, R. K. 1983. Bacterial cytochrome oxidases: a structurally and functionally diverse group of electron transfer proteins. Biochim. Biophys. Acta 726:205-243[Medline].
37. Probst, I., G. Wolf, and H. G. Schlegel. 1979. An O2-binding flavohemoprotein from Alcaligenes eutrophus. Biochim. Biophys. Acta 576:471-478[Medline].
38. Puustinen, A., M. Finel, T. Haltia, R. B. Gennis, and M. Wikström. 1991. Properties of the two terminal oxidases of Escherichia coli. Biochemistry 30:3936-3942[CrossRef][Medline].
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
40. Sauer, U., V. Hatzimanikatis, J. E. Bailey, M. Hochuli, T. Szyperski, and K. Wüthrich. 1997. Metabolic fluxes in riboflavin-producing Bacillus subtilis. Nat. Biotechnol. 15:448-452[CrossRef][Medline].
41. Sauer, U., D. R. Lasko, J. Fiaux, M. Hochuli, R. Glaser, T. Szyperski, K. Wüthrich, and J. E. Bailey. 1999. Metabolic flux ratio analysis of genetic and environmental modulations of Escherichia coli central carbon metabolism. J. Bacteriol. 181:6679-6688[Abstract/Free Full Text].
42. Shaka, A. J., J. Keeler, T. Frenkiel, and R. Freeman. 1983. An improved sequence for broad-band decoupling: Waltz-16. J. Magn. Reson. 52:335-338.
43. Szyperski, T. 1995. Biosynthetically directed fractional 13C-labeling of proteinogenic amino acids. An efficient analytical tool to investigate intermediary metabolism. Eur. J. Biochem. 232:433-448[Medline].
44. Szyperski, T., J. E. Bailey, and K. Wüthrich. 1996. Detecting and dissecting metabolic fluxes using biosynthetic fractional 13C labeling and two-dimensional NMR spectroscopy. Trends Biotechnol. 14:453-459[CrossRef].
45. Szyperski, T. 1998. 13C-NMR, MS and metabolic flux balancing in biotechnology research. Q. Rev. Biophys. 31:41-106[CrossRef][Medline].
46. Szyperski, T., R. W. Glauser, M. Hochuli, J. Fiaux, U. Sauer, J. E. Bailey, and K. Wüthrich. 1999. Bioreaction network topology and metabolic flux ratio analysis by biosynthetic fractional 13C labeling and two-dimensional NMR spectroscopy. Metabol. Engin. 1:189-197.
47. Tsai, P. S., G. Rao, and J. E. Bailey. 1995. Improvement of Escherichia coli microaerobic oxygen metabolism by Vitreoscilla hemoglobin: new insights from NAD(P)H fluorescence and culture redox potential. Biotechnol. Bioeng. 47:347-354[CrossRef].
48. Tsai, P. S., M. Nägeli, and J. E. Bailey. 1996. Intracellular expression of Vitreoscilla hemoglobin modifies microaerobic Escherichia coli metabolism through elevated concentration and specific activity of cytochrome o. Biotechnol. Bioeng. 49:151-160[CrossRef].
49. Tsai, P. S., V. Hatzimanikatis, and J. E. Bailey. 1996. Effect of Vitreoscilla hemoglobin dosage on microaerobic Escherichia coli carbon and energy metabolism. Biotechnol. Bioeng. 49:139-150[CrossRef].
50. Tyree, B., and D. A. Webster. 1978. The binding of cyanide and carbon monoxide to cytochrome o reductase associated with cytochrome o purified from Vitreoscilla. J. Biol. Chem. 249:4257-4260[Abstract/Free Full Text].
51. Webster, D. A. 1988. Structure and function of bacterial hemoglobin and related proteins, p. 245-265. In A. G. Sykes (ed.), Advances in inorganic biochemistry. Elsevier, New York, N.Y.
52. Wider, G., and K. Wüthrich. 1993. A simple experimental scheme using pulsed field gradients for coherence pathway rejection and solvent suppression in phase-sensitive heteronuclear correlation spectra. J. Magn. Reson. 102:239-241[CrossRef].


Applied and Environmental Microbiology, February 2001, p. 680-687, Vol. 67, No. 2
0099-2240/01/$04.00+0   DOI: 10.1128/AEM.67.2.680-687.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frey, A. D.
Right arrow Articles by Kallio, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frey, A. D.
Right arrow Articles by Kallio, P. T.
Agricola
Right arrow Articles by Frey, A. D.
Right arrow Articles by Kallio, P. T.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals